Company Overview

Perimeter Medical Imaging AI, Inc. is a medical technology company focused on developing advanced imaging and artificial intelligence tools designed to assist surgeons in real-time assessment of cancerous tissue. The company operates within the medical imaging, digital pathology, and surgical oncology industries, with a primary emphasis on improving intraoperative decision-making during cancer surgeries. Its core objective is to reduce the need for repeat surgeries by enabling more accurate identification of tumor margins during initial procedures.

The company’s primary business activity centers on its proprietary optical coherence tomography (OCT) imaging platform combined with artificial intelligence (AI) algorithms. This technology is intended to provide high-resolution, real-time visualization of tissue microstructures at the point of care. Perimeter Medical Imaging AI, Inc. was founded in 2013 and has evolved from a research-driven imaging company into a commercially focused medical device developer, advancing from prototype systems to regulatory-cleared products and clinical deployment, particularly in breast cancer surgery.

Business Operations

Perimeter Medical Imaging AI, Inc. generates revenue primarily through the development and commercialization of its medical imaging systems and related software. Its principal product, the Perimeter B-Scan® system, is designed for use during surgical procedures to scan excised tissue and assist clinicians in identifying cancerous margins. The system leverages OCT technology and is supported by ongoing development of AI-driven image analysis intended to enhance diagnostic accuracy. Commercial activity has historically been limited and supplemented by research funding, grants, and early-stage system placements.

The company conducts its operations through its wholly owned subsidiary, Perimeter Medical Imaging Inc., which houses the core research, development, and commercialization activities. While its current commercial focus is primarily in the United States and Canada, the company engages in collaborations with clinical research institutions and hospitals to support product validation, algorithm training, and regulatory submissions. There are no publicly disclosed joint ventures, but strategic clinical and academic partnerships play a key role in technology development.

Strategic Position & Investments

Perimeter Medical Imaging AI, Inc.’s strategic direction centers on expanding the clinical adoption of its OCT-based imaging platform and advancing its proprietary AI capabilities for real-time tissue classification. Growth initiatives include continued clinical studies, enhancement of machine-learning models, and incremental expansion into additional cancer indications beyond its initial breast cancer focus. The company positions itself at the intersection of imaging hardware and AI-enabled diagnostics, which it views as a key differentiator in the intraoperative imaging market.

Investment activity has largely been directed toward internal research and development rather than external acquisitions. The company has not disclosed material acquisitions of other operating businesses. Its strategic investments include software development, data infrastructure for AI training, and regulatory efforts to support expanded clinical claims. Emerging areas of focus include AI-assisted surgical guidance and broader applications of OCT imaging across oncologic and potentially other soft-tissue surgeries.

Geographic Footprint

Perimeter Medical Imaging AI, Inc. is headquartered in Canada, with its principal executive and development operations based in Ontario. The company maintains a significant operational and commercial focus in the United States, which represents its primary target market due to the size of the surgical oncology market and the importance of U.S. regulatory clearance.

Operational and clinical activities extend across North America, with system installations and clinical collaborations at hospitals and research institutions in both Canada and the United States. While the company does not currently report material revenue from other regions, it has indicated longer-term interest in expanding its market presence into Europe and other international healthcare markets, subject to regulatory approvals and commercialization partnerships.

Leadership & Governance

Perimeter Medical Imaging AI, Inc. was founded by Adrian Mendes, who has played a central role in shaping the company’s technology-driven and clinically focused strategy. The leadership team emphasizes a vision centered on evidence-based innovation, regulatory rigor, and close collaboration with surgeons and clinical researchers to address unmet needs in cancer care.

Key members of the executive leadership team include:

• Adrian Mendes – President and Chief Executive Officer
• Jeremy Sobotta – Chief Financial Officer
• Brian Bowering – Chief Technology Officer
• Jonah J. Hill – Vice President, Clinical & Regulatory Affairs

The company is governed by a board of directors that includes individuals with experience in medical devices, healthcare investment, and public company oversight, supporting its strategic objectives and compliance as a publicly traded issuer.